Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 6.60636341 |
2 | muscle filament sliding (GO:0030049) | 6.60636341 |
3 | actin-mediated cell contraction (GO:0070252) | 5.33898823 |
4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.24143407 |
5 | regulation of skeletal muscle contraction (GO:0014819) | 5.12450955 |
6 | skeletal muscle contraction (GO:0003009) | 4.90976707 |
7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.87039173 |
8 | ribosomal small subunit assembly (GO:0000028) | 4.67285678 |
9 | DNA deamination (GO:0045006) | 4.64613982 |
10 | regulation of relaxation of muscle (GO:1901077) | 4.61114675 |
11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.20094203 |
12 | ATP synthesis coupled proton transport (GO:0015986) | 4.20094203 |
13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.00562669 |
14 | respiratory electron transport chain (GO:0022904) | 3.94951571 |
15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.90660189 |
16 | electron transport chain (GO:0022900) | 3.85559352 |
17 | ubiquinone biosynthetic process (GO:0006744) | 3.80517792 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76220020 |
19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76220020 |
20 | IMP biosynthetic process (GO:0006188) | 3.74040228 |
21 | viral transcription (GO:0019083) | 3.72313947 |
22 | cullin deneddylation (GO:0010388) | 3.67121061 |
23 | translational termination (GO:0006415) | 3.64062614 |
24 | protein complex biogenesis (GO:0070271) | 3.59829577 |
25 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.58705694 |
26 | cytochrome complex assembly (GO:0017004) | 3.57663847 |
27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.57016762 |
28 | tricarboxylic acid cycle (GO:0006099) | 3.56542277 |
29 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.54990980 |
30 | NADH metabolic process (GO:0006734) | 3.50232278 |
31 | creatine metabolic process (GO:0006600) | 3.46111922 |
32 | actin filament-based movement (GO:0030048) | 3.45866172 |
33 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.44603207 |
34 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.41820025 |
35 | chaperone-mediated protein transport (GO:0072321) | 3.41085324 |
36 | negative regulation of ligase activity (GO:0051352) | 3.38611460 |
37 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.38611460 |
38 | ubiquinone metabolic process (GO:0006743) | 3.37167687 |
39 | response to muscle activity (GO:0014850) | 3.37076861 |
40 | protein deneddylation (GO:0000338) | 3.35842904 |
41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35735196 |
42 | maturation of SSU-rRNA (GO:0030490) | 3.34997794 |
43 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.34101946 |
44 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.34101946 |
45 | NADH dehydrogenase complex assembly (GO:0010257) | 3.34101946 |
46 | glycogen biosynthetic process (GO:0005978) | 3.33547680 |
47 | glucan biosynthetic process (GO:0009250) | 3.33547680 |
48 | purine nucleotide salvage (GO:0032261) | 3.33404068 |
49 | cotranslational protein targeting to membrane (GO:0006613) | 3.32184873 |
50 | protein targeting to ER (GO:0045047) | 3.30310434 |
51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29684714 |
52 | ribosome assembly (GO:0042255) | 3.29307345 |
53 | striated muscle contraction (GO:0006941) | 3.29239744 |
54 | CENP-A containing nucleosome assembly (GO:0034080) | 3.28560536 |
55 | translational elongation (GO:0006414) | 3.27300745 |
56 | chromatin remodeling at centromere (GO:0031055) | 3.26512619 |
57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26127253 |
58 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25959741 |
59 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.22170523 |
60 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.22170523 |
61 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.22170523 |
62 | inner mitochondrial membrane organization (GO:0007007) | 3.20906004 |
63 | protein localization to endoplasmic reticulum (GO:0070972) | 3.20727817 |
64 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.18872560 |
65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.18872560 |
66 | ribosomal small subunit biogenesis (GO:0042274) | 3.18161700 |
67 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.16319391 |
68 | aerobic respiration (GO:0009060) | 3.11413110 |
69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11054836 |
70 | protein neddylation (GO:0045116) | 3.11043850 |
71 | protein targeting to mitochondrion (GO:0006626) | 3.10047004 |
72 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.08649283 |
73 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.08649283 |
74 | glycogen catabolic process (GO:0005980) | 3.08178299 |
75 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.05687079 |
76 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.05585891 |
77 | establishment of integrated proviral latency (GO:0075713) | 3.03193878 |
78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.02773410 |
79 | myofibril assembly (GO:0030239) | 3.01984030 |
80 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.00868106 |
81 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.99508566 |
82 | positive regulation of ligase activity (GO:0051351) | 2.98844702 |
83 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.98474799 |
84 | transcription from mitochondrial promoter (GO:0006390) | 2.98067642 |
85 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.97548370 |
86 | DNA strand elongation (GO:0022616) | 2.97408316 |
87 | quinone biosynthetic process (GO:1901663) | 2.96064940 |
88 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.95946018 |
89 | purine nucleobase biosynthetic process (GO:0009113) | 2.95266066 |
90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.95204252 |
91 | L-phenylalanine metabolic process (GO:0006558) | 2.95204252 |
92 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.93470146 |
93 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.93470146 |
94 | nucleobase biosynthetic process (GO:0046112) | 2.92235869 |
95 | sarcomere organization (GO:0045214) | 2.91539443 |
96 | branched-chain amino acid catabolic process (GO:0009083) | 2.90803755 |
97 | skeletal muscle fiber development (GO:0048741) | 2.90217625 |
98 | proteasome assembly (GO:0043248) | 2.89197712 |
99 | regulation of glucokinase activity (GO:0033131) | 2.87748936 |
100 | regulation of hexokinase activity (GO:1903299) | 2.87748936 |
101 | protein localization to mitochondrion (GO:0070585) | 2.85578184 |
102 | serine family amino acid biosynthetic process (GO:0009070) | 2.85183761 |
103 | myotube cell development (GO:0014904) | 2.84140223 |
104 | aspartate family amino acid catabolic process (GO:0009068) | 2.84014915 |
105 | heart process (GO:0003015) | 2.83442711 |
106 | heart contraction (GO:0060047) | 2.83442711 |
107 | ribosomal large subunit biogenesis (GO:0042273) | 2.81639554 |
108 | glycine metabolic process (GO:0006544) | 2.79923091 |
109 | L-phenylalanine catabolic process (GO:0006559) | 2.79738521 |
110 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.79738521 |
111 | translational initiation (GO:0006413) | 2.75834992 |
112 | response to interferon-beta (GO:0035456) | 2.75599321 |
113 | NAD biosynthetic process (GO:0009435) | 2.74920622 |
114 | viral life cycle (GO:0019058) | 2.74621256 |
115 | tryptophan catabolic process (GO:0006569) | 2.72706095 |
116 | indole-containing compound catabolic process (GO:0042436) | 2.72706095 |
117 | indolalkylamine catabolic process (GO:0046218) | 2.72706095 |
118 | aromatic amino acid family catabolic process (GO:0009074) | 2.72168355 |
119 | imidazole-containing compound metabolic process (GO:0052803) | 2.71017828 |
120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70154919 |
121 | L-methionine salvage (GO:0071267) | 2.69972243 |
122 | L-methionine biosynthetic process (GO:0071265) | 2.69972243 |
123 | amino acid salvage (GO:0043102) | 2.69972243 |
124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69818577 |
125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.69019662 |
126 | cellular protein complex disassembly (GO:0043624) | 2.68951776 |
127 | tryptophan metabolic process (GO:0006568) | 2.67878167 |
128 | L-serine metabolic process (GO:0006563) | 2.67658495 |
129 | regulation of RIG-I signaling pathway (GO:0039535) | 2.66401178 |
130 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.65476648 |
131 | rRNA modification (GO:0000154) | 2.64964061 |
132 | DNA replication initiation (GO:0006270) | 2.64790263 |
133 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.64002161 |
134 | kynurenine metabolic process (GO:0070189) | 2.62530001 |
135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.60756909 |
136 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.59845546 |
137 | telomere maintenance via recombination (GO:0000722) | 2.59156088 |
138 | AMP metabolic process (GO:0046033) | 2.57944934 |
139 | valine metabolic process (GO:0006573) | 2.57031354 |
140 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.56221448 |
141 | purine nucleobase metabolic process (GO:0006144) | 2.55508377 |
142 | purine-containing compound salvage (GO:0043101) | 2.55229733 |
143 | regulation of mitochondrial translation (GO:0070129) | 2.54435817 |
144 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.54007907 |
145 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.54007907 |
146 | cellular response to interferon-beta (GO:0035458) | 2.52459087 |
147 | iron-sulfur cluster assembly (GO:0016226) | 2.51535197 |
148 | metallo-sulfur cluster assembly (GO:0031163) | 2.51535197 |
149 | folic acid metabolic process (GO:0046655) | 2.50394121 |
150 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.49749933 |
151 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.49364847 |
152 | translation (GO:0006412) | 2.49001133 |
153 | nucleoside salvage (GO:0043174) | 2.47684785 |
154 | serine family amino acid metabolic process (GO:0009069) | 2.45632020 |
155 | positive regulation of B cell differentiation (GO:0045579) | 2.45282090 |
156 | cellular metabolic compound salvage (GO:0043094) | 2.45278249 |
157 | pseudouridine synthesis (GO:0001522) | 2.43717772 |
158 | oxidative phosphorylation (GO:0006119) | 2.43108615 |
159 | tetrahydrofolate metabolic process (GO:0046653) | 2.41902929 |
160 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.41409371 |
161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.39613469 |
162 | methionine metabolic process (GO:0006555) | 2.39142782 |
163 | S-adenosylmethionine metabolic process (GO:0046500) | 2.38015561 |
164 | IMP metabolic process (GO:0046040) | 2.36372318 |
165 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.36100778 |
166 | regulation of triglyceride catabolic process (GO:0010896) | 2.35885302 |
167 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.33607288 |
168 | respiratory chain complex IV assembly (GO:0008535) | 2.31849305 |
169 | sulfur amino acid biosynthetic process (GO:0000097) | 2.31521675 |
170 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.31425071 |
171 | pteridine-containing compound metabolic process (GO:0042558) | 2.31092605 |
172 | cysteine metabolic process (GO:0006534) | 2.30881851 |
173 | positive regulation of interferon-alpha production (GO:0032727) | 2.30695237 |
174 | immunoglobulin mediated immune response (GO:0016064) | 2.30363128 |
175 | rRNA methylation (GO:0031167) | 2.30301609 |
176 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29912908 |
177 | sulfur amino acid catabolic process (GO:0000098) | 2.29559647 |
178 | necroptotic process (GO:0070266) | 2.29094644 |
179 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.28657555 |
180 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.28657555 |
181 | methionine biosynthetic process (GO:0009086) | 2.27442243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.35345750 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49136295 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36020603 |
4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.25329536 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16339410 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.01387905 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00617529 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.80070776 |
9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79044241 |
10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.75135493 |
11 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69770156 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.69754101 |
13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55553181 |
14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43283725 |
15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.40880669 |
16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39244505 |
17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38490565 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35514469 |
19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29121374 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.23551731 |
21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.18218319 |
22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08542779 |
23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06997138 |
24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.05175388 |
25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03223388 |
26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00742821 |
27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98292525 |
28 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93899194 |
29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90694726 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88652648 |
31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88029212 |
32 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87657196 |
33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86939145 |
34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84611132 |
35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84043489 |
36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83609009 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80784331 |
38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79534295 |
39 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79490633 |
40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75883629 |
41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.75458257 |
42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74265491 |
43 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73472733 |
44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71391688 |
45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69652499 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69080950 |
47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68803918 |
48 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66461453 |
49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66089729 |
50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63476063 |
51 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62464953 |
52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.60485747 |
53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58323320 |
54 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56967682 |
55 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56705886 |
56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55701700 |
57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55578233 |
58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52426082 |
59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52156040 |
60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51405563 |
61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50854250 |
62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48828031 |
63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46885056 |
64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46697596 |
65 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45256826 |
66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41882178 |
67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41717416 |
68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37281712 |
69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36833496 |
70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35765838 |
71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28664798 |
72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27009297 |
73 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24497971 |
74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23910045 |
75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23293135 |
76 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21991257 |
77 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21730881 |
78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20361953 |
79 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.19632241 |
80 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19057973 |
81 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19001782 |
82 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17521898 |
83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16491785 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15848132 |
85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15199083 |
86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14781762 |
87 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13255250 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12885874 |
89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.12771996 |
90 | MYC_22102868_ChIP-Seq_BL_Human | 1.12226903 |
91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09962281 |
92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09416124 |
93 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.08957310 |
94 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.08882043 |
95 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08278136 |
96 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08265633 |
97 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08245491 |
98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07378958 |
99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07370784 |
100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06988191 |
101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06974824 |
102 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.06884581 |
103 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06747515 |
104 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05661284 |
105 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05220249 |
106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04501934 |
107 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03070270 |
108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02762794 |
109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02048608 |
110 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01663101 |
111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00507066 |
112 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99929189 |
113 | MYB_26560356_Chip-Seq_TH2_Human | 0.99137821 |
114 | * MYB_26560356_Chip-Seq_TH1_Human | 0.98344170 |
115 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95261436 |
116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94863524 |
117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93617913 |
118 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93099192 |
119 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92961037 |
120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92498439 |
121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92194016 |
122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91142077 |
123 | MAF_26560356_Chip-Seq_TH1_Human | 0.89380584 |
124 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89209405 |
125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86561068 |
126 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.86348156 |
127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84710775 |
128 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84259017 |
129 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84050407 |
130 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.81845672 |
131 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.81135357 |
132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.80911848 |
133 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78163857 |
134 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76934766 |
135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.76009832 |
136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.75600528 |
137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.75600528 |
138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74786637 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 5.29235909 |
2 | MP0000749_muscle_degeneration | 4.64019664 |
3 | MP0000751_myopathy | 4.00057750 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.72837329 |
5 | MP0005360_urolithiasis | 3.35708502 |
6 | MP0004036_abnormal_muscle_relaxation | 3.30149600 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.25540359 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11543849 |
9 | MP0001835_abnormal_antigen_presentation | 2.94934837 |
10 | MP0005085_abnormal_gallbladder_physiolo | 2.93137826 |
11 | MP0002837_dystrophic_cardiac_calcinosis | 2.89227763 |
12 | MP0005365_abnormal_bile_salt | 2.83837015 |
13 | MP0002106_abnormal_muscle_physiology | 2.81464205 |
14 | MP0004084_abnormal_cardiac_muscle | 2.61195956 |
15 | MP0004147_increased_porphyrin_level | 2.58800152 |
16 | MP0005330_cardiomyopathy | 2.46525950 |
17 | MP0000747_muscle_weakness | 2.45533802 |
18 | MP0002269_muscular_atrophy | 2.42700358 |
19 | MP0009785_altered_susceptibility_to | 2.42605814 |
20 | MP0005369_muscle_phenotype | 2.37341814 |
21 | MP0005671_abnormal_response_to | 2.34389751 |
22 | MP0004087_abnormal_muscle_fiber | 2.28766316 |
23 | MP0001764_abnormal_homeostasis | 2.27074373 |
24 | MP0000759_abnormal_skeletal_muscle | 2.26637762 |
25 | MP0002396_abnormal_hematopoietic_system | 2.16276753 |
26 | MP0004233_abnormal_muscle_weight | 2.14063848 |
27 | MP0004215_abnormal_myocardial_fiber | 2.12272237 |
28 | MP0003693_abnormal_embryo_hatching | 2.09001398 |
29 | MP0003724_increased_susceptibility_to | 2.06023675 |
30 | MP0005620_abnormal_muscle_contractility | 2.02236945 |
31 | MP0000685_abnormal_immune_system | 2.01900249 |
32 | MP0002332_abnormal_exercise_endurance | 1.98645267 |
33 | MP0003656_abnormal_erythrocyte_physiolo | 1.92881247 |
34 | MP0006036_abnormal_mitochondrial_physio | 1.91620851 |
35 | MP0000372_irregular_coat_pigmentation | 1.91542331 |
36 | MP0005451_abnormal_body_composition | 1.90510899 |
37 | MP0009840_abnormal_foam_cell | 1.89445485 |
38 | MP0005025_abnormal_response_to | 1.88645825 |
39 | MP0003191_abnormal_cellular_cholesterol | 1.87776991 |
40 | MP0010094_abnormal_chromosome_stability | 1.85523259 |
41 | MP0003436_decreased_susceptibility_to | 1.79536686 |
42 | MP0001800_abnormal_humoral_immune | 1.79405146 |
43 | MP0003186_abnormal_redox_activity | 1.79034980 |
44 | MP0000750_abnormal_muscle_regeneration | 1.77384097 |
45 | MP0002166_altered_tumor_susceptibility | 1.69945782 |
46 | MP0010329_abnormal_lipoprotein_level | 1.68946361 |
47 | MP0002148_abnormal_hypersensitivity_rea | 1.65645774 |
48 | MP0002972_abnormal_cardiac_muscle | 1.65634531 |
49 | MP0008469_abnormal_protein_level | 1.63941763 |
50 | MP0001545_abnormal_hematopoietic_system | 1.63621205 |
51 | MP0005397_hematopoietic_system_phenotyp | 1.63621205 |
52 | MP0002723_abnormal_immune_serum | 1.62124854 |
53 | MP0005464_abnormal_platelet_physiology | 1.62013005 |
54 | MP0003763_abnormal_thymus_physiology | 1.61485242 |
55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58423964 |
56 | MP0005319_abnormal_enzyme/_coenzyme | 1.57857788 |
57 | MP0005000_abnormal_immune_tolerance | 1.56631710 |
58 | MP0001853_heart_inflammation | 1.56277501 |
59 | MP0002398_abnormal_bone_marrow | 1.50908490 |
60 | MP0008058_abnormal_DNA_repair | 1.50282101 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.50263746 |
62 | MP0006082_CNS_inflammation | 1.50198243 |
63 | MP0000689_abnormal_spleen_morphology | 1.49349772 |
64 | MP0005332_abnormal_amino_acid | 1.48928805 |
65 | MP0009333_abnormal_splenocyte_physiolog | 1.48744963 |
66 | MP0002452_abnormal_antigen_presenting | 1.48314854 |
67 | MP0001661_extended_life_span | 1.47991203 |
68 | MP0002419_abnormal_innate_immunity | 1.47313828 |
69 | MP0002132_abnormal_respiratory_system | 1.45352806 |
70 | MP0002420_abnormal_adaptive_immunity | 1.44144619 |
71 | MP0003718_maternal_effect | 1.43114884 |
72 | MP0001819_abnormal_immune_cell | 1.42325305 |
73 | MP0000609_abnormal_liver_physiology | 1.42156810 |
74 | MP0005387_immune_system_phenotype | 1.42133335 |
75 | MP0001790_abnormal_immune_system | 1.42133335 |
76 | MP0002006_tumorigenesis | 1.41898545 |
77 | MP0008057_abnormal_DNA_replication | 1.40860244 |
78 | MP0003252_abnormal_bile_duct | 1.40212396 |
79 | MP0002722_abnormal_immune_system | 1.35457926 |
80 | MP0000716_abnormal_immune_system | 1.34626890 |
81 | MP0004808_abnormal_hematopoietic_stem | 1.32615433 |
82 | MP0002127_abnormal_cardiovascular_syste | 1.32118148 |
83 | MP0009697_abnormal_copulation | 1.31421340 |
84 | MP0002429_abnormal_blood_cell | 1.30807238 |
85 | MP0005075_abnormal_melanosome_morpholog | 1.30269205 |
86 | MP0001529_abnormal_vocalization | 1.29887579 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28219083 |
88 | MP0005636_abnormal_mineral_homeostasis | 1.28193712 |
89 | MP0001845_abnormal_inflammatory_respons | 1.27614697 |
90 | MP0001666_abnormal_nutrient_absorption | 1.27573450 |
91 | MP0008877_abnormal_DNA_methylation | 1.24296074 |
92 | MP0004130_abnormal_muscle_cell | 1.23814600 |
93 | MP0003077_abnormal_cell_cycle | 1.22682988 |
94 | MP0000465_gastrointestinal_hemorrhage | 1.22448871 |
95 | MP0002138_abnormal_hepatobiliary_system | 1.20207964 |
96 | MP0002108_abnormal_muscle_morphology | 1.19854341 |
97 | MP0001544_abnormal_cardiovascular_syste | 1.19354555 |
98 | MP0005385_cardiovascular_system_phenoty | 1.19354555 |
99 | MP0008932_abnormal_embryonic_tissue | 1.17670189 |
100 | MP0005083_abnormal_biliary_tract | 1.17346922 |
101 | MP0010155_abnormal_intestine_physiology | 1.15398865 |
102 | MP0003137_abnormal_impulse_conducting | 1.15047088 |
103 | MP0009643_abnormal_urine_homeostasis | 1.14841271 |
104 | MP0009763_increased_sensitivity_to | 1.13302338 |
105 | MP0004484_altered_response_of | 1.09875469 |
106 | MP0000598_abnormal_liver_morphology | 1.08885563 |
107 | MP0002876_abnormal_thyroid_physiology | 1.08537035 |
108 | MP0000490_abnormal_crypts_of | 1.07840819 |
109 | MP0006035_abnormal_mitochondrial_morpho | 1.05926847 |
110 | MP0002019_abnormal_tumor_incidence | 1.04325980 |
111 | MP0009764_decreased_sensitivity_to | 1.01681663 |
112 | MP0008007_abnormal_cellular_replicative | 1.00626692 |
113 | MP0003646_muscle_fatigue | 1.00394308 |
114 | MP0003866_abnormal_defecation | 1.00152196 |
115 | MP0006292_abnormal_olfactory_placode | 0.99025878 |
116 | MP0003111_abnormal_nucleus_morphology | 0.98977459 |
117 | MP0003950_abnormal_plasma_membrane | 0.98901065 |
118 | MP0002118_abnormal_lipid_homeostasis | 0.98654804 |
119 | MP0002102_abnormal_ear_morphology | 0.98643228 |
120 | MP0004019_abnormal_vitamin_homeostasis | 0.97281312 |
121 | MP0005058_abnormal_lysosome_morphology | 0.96864567 |
122 | MP0006072_abnormal_retinal_apoptosis | 0.96710095 |
123 | MP0003011_delayed_dark_adaptation | 0.93580620 |
124 | MP0010630_abnormal_cardiac_muscle | 0.92067552 |
125 | MP0002095_abnormal_skin_pigmentation | 0.90324673 |
126 | MP0004185_abnormal_adipocyte_glucose | 0.90265545 |
127 | MP0005376_homeostasis/metabolism_phenot | 0.90022643 |
128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89341026 |
129 | MP0008775_abnormal_heart_ventricle | 0.88263641 |
130 | MP0003868_abnormal_feces_composition | 0.88147458 |
131 | MP0003195_calcinosis | 0.87388328 |
132 | MP0008995_early_reproductive_senescence | 0.87223788 |
133 | MP0009379_abnormal_foot_pigmentation | 0.86836315 |
134 | MP0002405_respiratory_system_inflammati | 0.85968704 |
135 | MP0000343_altered_response_to | 0.85529635 |
136 | MP0005266_abnormal_metabolism | 0.85246379 |
137 | MP0004782_abnormal_surfactant_physiolog | 0.85031405 |
138 | MP0005174_abnormal_tail_pigmentation | 0.83666796 |
139 | MP0004142_abnormal_muscle_tone | 0.83197111 |
140 | MP0005084_abnormal_gallbladder_morpholo | 0.81941843 |
141 | MP0003786_premature_aging | 0.81811501 |
142 | MP0002877_abnormal_melanocyte_morpholog | 0.81430428 |
143 | MP0009642_abnormal_blood_homeostasis | 0.80941090 |
144 | MP0001873_stomach_inflammation | 0.80640726 |
145 | MP0009765_abnormal_xenobiotic_induced | 0.79461783 |
146 | MP0002163_abnormal_gland_morphology | 0.78792586 |
147 | MP0005670_abnormal_white_adipose | 0.78537422 |
148 | MP0000733_abnormal_muscle_development | 0.78056409 |
149 | MP0005645_abnormal_hypothalamus_physiol | 0.76403189 |
150 | MP0002638_abnormal_pupillary_reflex | 0.72508681 |
151 | MP0000013_abnormal_adipose_tissue | 0.72380579 |
152 | MP0001929_abnormal_gametogenesis | 0.71607354 |
153 | MP0001730_embryonic_growth_arrest | 0.68401598 |
154 | MP0006138_congestive_heart_failure | 0.68307540 |
155 | MP0000358_abnormal_cell_content/ | 0.65321032 |
156 | MP0001293_anophthalmia | 0.64658924 |
157 | MP0002971_abnormal_brown_adipose | 0.62988914 |
158 | MP0005253_abnormal_eye_physiology | 0.62045623 |
159 | MP0005666_abnormal_adipose_tissue | 0.61068375 |
160 | MP0000313_abnormal_cell_death | 0.60503735 |
161 | MP0002210_abnormal_sex_determination | 0.58249096 |
162 | MP0004085_abnormal_heartbeat | 0.55931986 |
163 | MP0001697_abnormal_embryo_size | 0.53994768 |
164 | MP0001727_abnormal_embryo_implantation | 0.53859146 |
165 | MP0002234_abnormal_pharynx_morphology | 0.53500316 |
166 | MP0000653_abnormal_sex_gland | 0.52490702 |
167 | MP0001145_abnormal_male_reproductive | 0.52295669 |
168 | MP0008789_abnormal_olfactory_epithelium | 0.49674665 |
169 | MP0005452_abnormal_adipose_tissue | 0.49134033 |
170 | MP0008872_abnormal_physiological_respon | 0.49027270 |
171 | MP0002078_abnormal_glucose_homeostasis | 0.48178688 |
172 | MP0000350_abnormal_cell_proliferation | 0.47204449 |
173 | MP0002822_catalepsy | 0.46863463 |
174 | MP0009672_abnormal_birth_weight | 0.46821827 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 8.76650834 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 8.62502706 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.30983515 |
4 | Exercise-induced muscle cramps (HP:0003710) | 6.31262704 |
5 | Exercise-induced myalgia (HP:0003738) | 5.80816122 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 5.18214795 |
7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.75858998 |
8 | Distal arthrogryposis (HP:0005684) | 4.32253102 |
9 | Rhabdomyolysis (HP:0003201) | 4.26723251 |
10 | Calf muscle hypertrophy (HP:0008981) | 4.16767300 |
11 | Myoglobinuria (HP:0002913) | 4.04572255 |
12 | Aplastic anemia (HP:0001915) | 3.98470639 |
13 | EMG: myopathic abnormalities (HP:0003458) | 3.91929063 |
14 | Rimmed vacuoles (HP:0003805) | 3.86577090 |
15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.85105100 |
16 | Myopathic facies (HP:0002058) | 3.83428006 |
17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.72784283 |
18 | Abnormal number of erythroid precursors (HP:0012131) | 3.65855583 |
19 | Hepatic necrosis (HP:0002605) | 3.42678267 |
20 | Neck muscle weakness (HP:0000467) | 3.39469497 |
21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.24974237 |
22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.24974237 |
23 | Progressive macrocephaly (HP:0004481) | 3.21733043 |
24 | Thrombocytosis (HP:0001894) | 3.20615755 |
25 | Hepatocellular necrosis (HP:0001404) | 3.19410859 |
26 | Exercise intolerance (HP:0003546) | 3.15200353 |
27 | IgM deficiency (HP:0002850) | 3.11574871 |
28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.10564120 |
29 | Muscle stiffness (HP:0003552) | 3.08698750 |
30 | Abnormality of the calf musculature (HP:0001430) | 3.07856669 |
31 | Hypobetalipoproteinemia (HP:0003563) | 3.06527568 |
32 | Generalized aminoaciduria (HP:0002909) | 2.99289605 |
33 | Muscle fiber splitting (HP:0003555) | 2.98058695 |
34 | Round ear (HP:0100830) | 2.97344955 |
35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94911014 |
36 | Absent phalangeal crease (HP:0006109) | 2.89684720 |
37 | Prolonged partial thromboplastin time (HP:0003645) | 2.85943196 |
38 | Areflexia of lower limbs (HP:0002522) | 2.85927704 |
39 | Calcaneovalgus deformity (HP:0001848) | 2.81164196 |
40 | Progressive muscle weakness (HP:0003323) | 2.81061010 |
41 | Ulnar deviation of the wrist (HP:0003049) | 2.80984491 |
42 | Subaortic stenosis (HP:0001682) | 2.80441680 |
43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.80441680 |
44 | Hyperglycinemia (HP:0002154) | 2.76443354 |
45 | Hyporeflexia of lower limbs (HP:0002600) | 2.75705661 |
46 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.71392303 |
47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70773225 |
48 | Myotonia (HP:0002486) | 2.70663801 |
49 | Reduced antithrombin III activity (HP:0001976) | 2.70239123 |
50 | Petechiae (HP:0000967) | 2.68800633 |
51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.64176873 |
52 | Intrahepatic cholestasis (HP:0001406) | 2.63793162 |
53 | Hyperammonemia (HP:0001987) | 2.62981983 |
54 | Reticulocytopenia (HP:0001896) | 2.62244816 |
55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.57238956 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.55451054 |
57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55451054 |
58 | Deformed tarsal bones (HP:0008119) | 2.53115781 |
59 | Vacuolated lymphocytes (HP:0001922) | 2.53044508 |
60 | Increased muscle lipid content (HP:0009058) | 2.52849223 |
61 | Abnormal finger flexion creases (HP:0006143) | 2.52104535 |
62 | Recurrent bronchitis (HP:0002837) | 2.50540567 |
63 | Macrocytic anemia (HP:0001972) | 2.48863188 |
64 | Chronic otitis media (HP:0000389) | 2.47205739 |
65 | Hypoglycemic coma (HP:0001325) | 2.46549954 |
66 | Hyperbilirubinemia (HP:0002904) | 2.46322304 |
67 | Ketosis (HP:0001946) | 2.44437074 |
68 | Increased serum lactate (HP:0002151) | 2.44386405 |
69 | Mitochondrial inheritance (HP:0001427) | 2.43145974 |
70 | Malignant hyperthermia (HP:0002047) | 2.42660979 |
71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42234562 |
72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.42091366 |
73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40446149 |
74 | Abnormality of glycine metabolism (HP:0010895) | 2.40446149 |
75 | Hypoplasia of the thymus (HP:0000778) | 2.39889034 |
76 | Increased CSF lactate (HP:0002490) | 2.39850778 |
77 | Lactic acidosis (HP:0003128) | 2.39567035 |
78 | Type 2 muscle fiber atrophy (HP:0003554) | 2.39116901 |
79 | Cerebral edema (HP:0002181) | 2.38443607 |
80 | Abnormality of serum amino acid levels (HP:0003112) | 2.36083525 |
81 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36078470 |
82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35402393 |
83 | Pallor (HP:0000980) | 2.33253459 |
84 | Increased serum pyruvate (HP:0003542) | 2.32446371 |
85 | 3-Methylglutaconic aciduria (HP:0003535) | 2.30656639 |
86 | Abnormal spermatogenesis (HP:0008669) | 2.29940120 |
87 | Joint hemorrhage (HP:0005261) | 2.29491687 |
88 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28945789 |
89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.28161843 |
90 | Pancytopenia (HP:0001876) | 2.27281127 |
91 | Abnormality of T cell physiology (HP:0011840) | 2.27150693 |
92 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.27052553 |
93 | Hyperglycinuria (HP:0003108) | 2.26756296 |
94 | Xanthomatosis (HP:0000991) | 2.25615358 |
95 | Sudden death (HP:0001699) | 2.23920691 |
96 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22087922 |
97 | Type I transferrin isoform profile (HP:0003642) | 2.21724854 |
98 | Microvesicular hepatic steatosis (HP:0001414) | 2.20601745 |
99 | Nasal polyposis (HP:0100582) | 2.20085509 |
100 | Acute encephalopathy (HP:0006846) | 2.18520203 |
101 | Respiratory failure (HP:0002878) | 2.16842374 |
102 | Weak cry (HP:0001612) | 2.16075669 |
103 | Difficulty running (HP:0009046) | 2.13941634 |
104 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13523716 |
105 | Epistaxis (HP:0000421) | 2.11870862 |
106 | Frequent falls (HP:0002359) | 2.10756627 |
107 | Lethargy (HP:0001254) | 2.09490287 |
108 | Acute necrotizing encephalopathy (HP:0006965) | 2.08449305 |
109 | Myositis (HP:0100614) | 2.06882258 |
110 | Muscle fiber atrophy (HP:0100295) | 2.06300152 |
111 | Hyperalaninemia (HP:0003348) | 2.06167261 |
112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.06167261 |
113 | Abnormality of alanine metabolism (HP:0010916) | 2.06167261 |
114 | Abnormality of glycolysis (HP:0004366) | 2.04808615 |
115 | Dilated cardiomyopathy (HP:0001644) | 2.04795004 |
116 | Neutropenia (HP:0001875) | 2.03456300 |
117 | IgG deficiency (HP:0004315) | 2.02684194 |
118 | Fat malabsorption (HP:0002630) | 2.01983318 |
119 | Metabolic acidosis (HP:0001942) | 2.01925557 |
120 | Generalized muscle weakness (HP:0003324) | 1.99420317 |
121 | Hyperlipoproteinemia (HP:0010980) | 1.99376774 |
122 | Increased serum ferritin (HP:0003281) | 1.98038249 |
123 | Gout (HP:0001997) | 1.97183488 |
124 | EMG: neuropathic changes (HP:0003445) | 1.96232657 |
125 | Birth length less than 3rd percentile (HP:0003561) | 1.95822154 |
126 | Limb-girdle muscle atrophy (HP:0003797) | 1.94939288 |
127 | Oral leukoplakia (HP:0002745) | 1.94610034 |
128 | Renal Fanconi syndrome (HP:0001994) | 1.92670735 |
129 | Abnormality of the nasal mucosa (HP:0000433) | 1.91121804 |
130 | Nausea (HP:0002018) | 1.90819810 |
131 | Poikiloderma (HP:0001029) | 1.90286449 |
132 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89977456 |
133 | Deep venous thrombosis (HP:0002625) | 1.89483623 |
134 | Abnormality of iron homeostasis (HP:0011031) | 1.88977595 |
135 | Bundle branch block (HP:0011710) | 1.88000275 |
136 | Abnormality of T cells (HP:0002843) | 1.87578397 |
137 | Impaired platelet aggregation (HP:0003540) | 1.86675234 |
138 | Abnormal platelet function (HP:0011869) | 1.86675234 |
139 | Palpitations (HP:0001962) | 1.85835763 |
140 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85271330 |
141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85271330 |
142 | Abnormal protein glycosylation (HP:0012346) | 1.85271330 |
143 | Abnormal glycosylation (HP:0012345) | 1.85271330 |
144 | Abnormality of B cell number (HP:0010975) | 1.85190017 |
145 | B lymphocytopenia (HP:0010976) | 1.85190017 |
146 | Ragged-red muscle fibers (HP:0003200) | 1.84986319 |
147 | Azoospermia (HP:0000027) | 1.84348318 |
148 | Asymmetric septal hypertrophy (HP:0001670) | 1.82973839 |
149 | CNS demyelination (HP:0007305) | 1.80842571 |
150 | Methylmalonic acidemia (HP:0002912) | 1.80835797 |
151 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80050923 |
152 | Exertional dyspnea (HP:0002875) | 1.79634317 |
153 | Microretrognathia (HP:0000308) | 1.79603483 |
154 | Optic disc pallor (HP:0000543) | 1.79296961 |
155 | Paralysis (HP:0003470) | 1.78131287 |
156 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72850913 |
157 | Facial diplegia (HP:0001349) | 1.72665425 |
158 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72013381 |
159 | Shoulder girdle muscle weakness (HP:0003547) | 1.70872990 |
160 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.70364824 |
161 | Distal lower limb muscle weakness (HP:0009053) | 1.67829876 |
162 | Colon cancer (HP:0003003) | 1.64129396 |
163 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.62622133 |
164 | Fetal akinesia sequence (HP:0001989) | 1.61196949 |
165 | Multiple enchondromatosis (HP:0005701) | 1.58541202 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.24828301 |
2 | PHKG2 | 3.76460692 |
3 | PHKG1 | 3.76460692 |
4 | NME2 | 3.41534575 |
5 | WEE1 | 3.27337332 |
6 | VRK2 | 3.06970725 |
7 | BUB1 | 2.97921700 |
8 | BCKDK | 2.97515903 |
9 | EIF2AK1 | 2.93916746 |
10 | NEK1 | 2.93654719 |
11 | KIT | 2.85446998 |
12 | STK16 | 2.76084765 |
13 | MAP4K1 | 2.59138758 |
14 | TTN | 2.52252296 |
15 | MAP2K3 | 2.40562647 |
16 | FLT3 | 2.35555630 |
17 | EIF2AK3 | 2.30527720 |
18 | BRSK2 | 2.15105932 |
19 | ACVR1B | 2.07253575 |
20 | TEC | 1.91295361 |
21 | MAP4K2 | 1.90861600 |
22 | PIK3CG | 1.84200360 |
23 | BMPR1B | 1.83554086 |
24 | PINK1 | 1.80365380 |
25 | TBK1 | 1.79534555 |
26 | TYK2 | 1.76251277 |
27 | ZAK | 1.75616977 |
28 | VRK1 | 1.74707084 |
29 | BTK | 1.66488315 |
30 | NEK9 | 1.60537107 |
31 | RPS6KA4 | 1.59002080 |
32 | NUAK1 | 1.51708254 |
33 | TTK | 1.50762288 |
34 | TSSK6 | 1.48481539 |
35 | PLK3 | 1.46353918 |
36 | SRPK1 | 1.42606246 |
37 | CSF1R | 1.41121476 |
38 | IRAK4 | 1.40284205 |
39 | IRAK3 | 1.39728781 |
40 | PKN2 | 1.37286084 |
41 | ERN1 | 1.35563711 |
42 | KDR | 1.30363629 |
43 | IKBKE | 1.28405584 |
44 | PDK4 | 1.24330304 |
45 | PDK3 | 1.24330304 |
46 | CDC7 | 1.24263164 |
47 | NEK2 | 1.24017975 |
48 | MAP3K14 | 1.23465074 |
49 | TRIM28 | 1.23383937 |
50 | NME1 | 1.22163496 |
51 | SYK | 1.18741169 |
52 | PIM2 | 1.16110721 |
53 | JAK3 | 1.15850953 |
54 | ZAP70 | 1.15617385 |
55 | TXK | 1.14488938 |
56 | PASK | 1.11451314 |
57 | MAPK11 | 1.11196994 |
58 | CCNB1 | 1.07882635 |
59 | MAP3K3 | 1.07287270 |
60 | RPS6KB2 | 1.02618596 |
61 | DYRK3 | 1.02220571 |
62 | TAOK3 | 1.01755919 |
63 | MAP2K6 | 1.01430848 |
64 | CDK8 | 1.01331786 |
65 | WNK3 | 0.98652138 |
66 | TESK2 | 0.97681978 |
67 | FGFR4 | 0.97275559 |
68 | ERBB3 | 0.96853386 |
69 | IKBKB | 0.91102376 |
70 | BLK | 0.90794952 |
71 | ATR | 0.90634928 |
72 | LYN | 0.88711598 |
73 | PBK | 0.87807367 |
74 | BRSK1 | 0.87651017 |
75 | PDK2 | 0.87189289 |
76 | TAF1 | 0.85026835 |
77 | CDK4 | 0.84570433 |
78 | MATK | 0.81345851 |
79 | MAP3K6 | 0.80993705 |
80 | MKNK2 | 0.76654543 |
81 | MYLK | 0.74782682 |
82 | MAPKAPK3 | 0.72466075 |
83 | EEF2K | 0.71849174 |
84 | MAP3K11 | 0.70060777 |
85 | TGFBR1 | 0.69403835 |
86 | TLK1 | 0.67772681 |
87 | GRK6 | 0.65884406 |
88 | MAPK12 | 0.64541083 |
89 | AURKB | 0.63932734 |
90 | MAP3K12 | 0.63565901 |
91 | PIM1 | 0.63313954 |
92 | TIE1 | 0.63190133 |
93 | PLK4 | 0.60091585 |
94 | EIF2AK2 | 0.59868724 |
95 | NLK | 0.59013160 |
96 | LRRK2 | 0.58008064 |
97 | MAP2K4 | 0.57723241 |
98 | ABL2 | 0.56260177 |
99 | CDK7 | 0.55994467 |
100 | TGFBR2 | 0.55860152 |
101 | CSNK1G1 | 0.54910953 |
102 | LCK | 0.54287658 |
103 | GRK1 | 0.53152261 |
104 | LIMK1 | 0.51959358 |
105 | PLK1 | 0.51148376 |
106 | MST4 | 0.50596873 |
107 | CSNK2A1 | 0.50445505 |
108 | AKT2 | 0.50264629 |
109 | DAPK1 | 0.50097179 |
110 | ADRBK2 | 0.49080420 |
111 | CSNK2A2 | 0.48818620 |
112 | CAMKK2 | 0.47856227 |
113 | CSNK1G3 | 0.47641956 |
114 | CDK19 | 0.47014298 |
115 | CHEK2 | 0.45710447 |
116 | JAK1 | 0.45274326 |
117 | MUSK | 0.44976366 |
118 | ITK | 0.44697610 |
119 | MAP3K5 | 0.44296903 |
120 | MAP3K7 | 0.43049311 |
121 | ATM | 0.42654104 |
122 | PRKG2 | 0.42348028 |
123 | SCYL2 | 0.41960806 |
124 | AURKA | 0.41049024 |
125 | TNIK | 0.41018095 |
126 | MKNK1 | 0.39710742 |
127 | JAK2 | 0.38884285 |
128 | STK4 | 0.38284256 |
129 | DYRK1B | 0.38097305 |
130 | PAK4 | 0.36983332 |
131 | BCR | 0.34078095 |
132 | CAMK2G | 0.33137350 |
133 | CHEK1 | 0.30387447 |
134 | PRKAA1 | 0.28000604 |
135 | PRKG1 | 0.27798062 |
136 | PLK2 | 0.27765793 |
137 | CDK9 | 0.27561085 |
138 | CSNK1G2 | 0.26955681 |
139 | MAP2K7 | 0.26866675 |
140 | PRKACB | 0.26821281 |
141 | DYRK2 | 0.24950111 |
142 | PRKDC | 0.24651216 |
143 | CAMK2A | 0.24212122 |
144 | PRKACA | 0.24088943 |
145 | OXSR1 | 0.23804963 |
146 | STK10 | 0.23539352 |
147 | RPS6KB1 | 0.23145621 |
148 | CAMK2D | 0.23024899 |
149 | PRKAA2 | 0.22823064 |
150 | PRKCQ | 0.22268032 |
151 | INSRR | 0.21132237 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.02363205 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.97039171 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46648732 |
4 | Proteasome_Homo sapiens_hsa03050 | 2.44696059 |
5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.44651700 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.16544556 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.07827515 |
8 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.06890841 |
9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.04893362 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.04794268 |
11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.01479182 |
12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.95906419 |
13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.91631482 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91172232 |
15 | RNA polymerase_Homo sapiens_hsa03020 | 1.90077308 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76355590 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74036877 |
18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67085147 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.64391248 |
20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.63895351 |
21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60388385 |
22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60289487 |
23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.59545022 |
24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.57108068 |
25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55395556 |
26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52755174 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.50105488 |
28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50105302 |
29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.48791122 |
30 | Protein export_Homo sapiens_hsa03060 | 1.45416232 |
31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.45110094 |
32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45006335 |
33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44986153 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.44572231 |
35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44544220 |
36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.36656773 |
37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36270456 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33162578 |
39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33080060 |
40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28767383 |
41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28088030 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27495534 |
43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24907663 |
44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23822004 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23794563 |
46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20728810 |
47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20589423 |
48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20272478 |
49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19513779 |
50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13997491 |
51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13412372 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07656896 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06539469 |
54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05495805 |
55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03043607 |
56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02451991 |
57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99933929 |
58 | Spliceosome_Homo sapiens_hsa03040 | 0.99793780 |
59 | Purine metabolism_Homo sapiens_hsa00230 | 0.99360719 |
60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94932791 |
61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94810160 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90240967 |
63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89556458 |
64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88991871 |
65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85446227 |
66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85250335 |
67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83373635 |
68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81673854 |
69 | Legionellosis_Homo sapiens_hsa05134 | 0.81194108 |
70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81015622 |
71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.78479173 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78393976 |
73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78053780 |
74 | RNA transport_Homo sapiens_hsa03013 | 0.77806045 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76299608 |
76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75434161 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75279497 |
78 | ABC transporters_Homo sapiens_hsa02010 | 0.75220656 |
79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74182033 |
80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73772322 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72901303 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71174022 |
83 | RNA degradation_Homo sapiens_hsa03018 | 0.70503599 |
84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70442924 |
85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69761781 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68887392 |
87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67961919 |
88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67706983 |
89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67351410 |
90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64918425 |
91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64239411 |
92 | Measles_Homo sapiens_hsa05162 | 0.62349928 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58902883 |
94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57335031 |
95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57298035 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57219382 |
97 | Cell cycle_Homo sapiens_hsa04110 | 0.54600079 |
98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53337628 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52273441 |
100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50961858 |
101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50813830 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49565453 |
103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48852991 |
104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48124665 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47147566 |
106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46916602 |
107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46553525 |
108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45915538 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44430008 |
110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42750201 |
111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42747934 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40857914 |
113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39139977 |
114 | Phototransduction_Homo sapiens_hsa04744 | 0.37213809 |
115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29857251 |
116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27932179 |
117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25607186 |
118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22752911 |
119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16727105 |
120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14041255 |
121 | Asthma_Homo sapiens_hsa05310 | 0.11080668 |
122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.10708950 |
123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09793533 |
124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05994495 |
125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04687891 |